Ozurdex (Dexamethasone)

Dexamethasone, the active ingredient in Ozurdex, is a corticosteroid presented as a dexamethasone intravitreal implant for ocular use. It treats macular edema associated with retinal vein occlusion, non‑infectious uveitis, and diabetic macular edema in adult patients. GNH USA supplies Ozurdex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and ophthalmology clinics worldwide.

GNH USA supplies Ozurdex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and ophthalmology clinics worldwide.

Ozurdex is a corticosteroid implant that delivers a sustained release of dexamethasone to the posterior segment of the eye, addressing several retinal conditions.

- Macular edema secondary to retinal vein occlusion: reduces the thickness and improves visual acuity. - Non‑infectious intermediate‑posterior uveitis: controls inflammation and prevents vision loss. - Diabetic macular edema: decreases retinal swelling and stabilises visual function. - Post‑operative post‑cataract inflammation: mitigates inflammation after surgery.